Date published: 2025-10-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

MMP-9/MMP-13 inhibitor I (CAS 204140-01-2)

5.0(1)
Write a reviewAsk a question

See product citations (2)

Alternate Names:
N-Hydroxy-1-(4-methoxyphenyl)sulfonyl-4-(4-biphenylcarbonyl)piperazine-2-carboxamide
Application:
MMP-9/MMP-13 inhibitor I is a piperazine-based, cell-permeable inhibitor of MMP-9 and MMP-13
CAS Number:
204140-01-2
Purity:
≥95%
Molecular Weight:
495.55
Molecular Formula:
C25H25N3O6S
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

MMP-9/MMP-13 Inhibitor I is a piperazine-based, cell-permeable, and highly potent inhibitor of MMP-9 (IC50 = 900 pM) and MMP-13 (IC50 = 900 pM). Reported to inhibit MMP-1 and MMP-3 at much higher concentrations (IC50 = 43 nM and 23 nM, respectively). Also acts as an inhibitor of MMP-7 (IC50 = 930 nM)(MMPs) are a group of zinc-dependent endopeptidases that play a vital role in processes like tissue remodeling and inflammation. Among these, MMP-9 and MMP-13 are prominent members responsible for breaking down extracellular matrix proteins. One such promising inhibitor, known as MMP-9/MMP-13 inhibitor I, has undergone extensive research. Moreover, scientists have explored MMP-9/MMP-13 inhibitor I′s ability to modulate the inflammatory response.


MMP-9/MMP-13 inhibitor I (CAS 204140-01-2) References

  1. Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.  |  Cheng, M., et al. 2000. J Med Chem. 43: 369-80. PMID: 10669564
  2. Phagocytosis of hemozoin enhances matrix metalloproteinase-9 activity and TNF-alpha production in human monocytes: role of matrix metalloproteinases in the pathogenesis of falciparum malaria.  |  Prato, M., et al. 2005. J Immunol. 175: 6436-42. PMID: 16272296

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

MMP-9/MMP-13 inhibitor I, 1 mg

sc-311438
1 mg
$173.00

MMP-9/MMP-13 inhibitor I, 5 mg

sc-311438A
5 mg
$536.00